NCT00274430已完成1 期
A Randomized Controlled Trial of the Effects of Tadalafil and Dexamethasone Versus Placebo on Pulmonary Edema Formation and Cerebral Blood Flow Autoregulation in High Altitude Newcomers With a Previous History of High Altitude Pulmonary Edema
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
- 主要终点
- prevention of high altitude pulmonary edema
研究概览
简要总结
A double-blind placebo controlled study
- To compare the effect of tadalafil and dexamethasone versus placebo on Ppa and pulmonary edema formation in subjects susceptible to HAPE.
- To investigate the effect of dexamethasone on alveolar fluid clearance, as assessed by measurement of the nasal potential difference, and prevention of HAPE.
- To investigate the effect of the tadalafil and dexamethasone versus placebo on the dynamic CBF autoregulation properties and on the development of AMS in HAPE susceptible subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •At least one previous episode of high altitude pulmonary edema
排除标准
- •pulmonary arterial hypertension
- •congenital heart disease
- •any chronic lung disease
结局指标
主要结局
prevention of high altitude pulmonary edema
次要结局
- incidence of acute mountain sickness
研究者
相似试验
已完成
2 期
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach EmptyingGastroparesisNCT00050609Eli Lilly and Company2
已完成
不适用
Evaluation of the Effect of Adding Dexamethasone to 2% LidocainePulpitis - IrreversibleNCT05361291Jamia Millia Islamia124
已完成
3 期
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord InjurySpinal Cord InjuriesErectile DysfunctionNCT00421083Eli Lilly and Company180
已完成
3 期
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination TreatmentProstatic HyperplasiaNCT00090103GlaxoSmithKline4,844
已完成
2 期
Tadalafil in Subjects With Mild to Moderate HypertensionHypertensionNCT00157326Eli Lilly and Company180
